Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-11 1:50 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Flynn James E | 1,324,214 5.04% | 1,324,214 (New Position) | View |
| 2022-02-14 5:28 pm Unchanged | 13G | TARSUS PHARMACEUTICALS INC TARS | PERCEPTIVE ADVISORS LLC | 1,296,416 6.3% | 0 (Unchanged) | View |
| 2022-02-14 4:46 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Azamian Bobak R. | 1,426,091 6.8% | -489,204 (-25.54%) | View |
| 2022-02-14 4:45 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Ackermann Michael | 1,261,666 6.1% | -205,354 (-14.00%) | View |
| 2022-02-14 3:01 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,403,331 6.79% | -310,938 (-18.14%) | View |
| 2022-02-14 08:18 am Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,013,601 9.7% | -450,000 (-18.27%) | View |
| 2022-02-11 5:21 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX LLC | 2,987,331 14.4% | -257,704 (-7.94%) | View |
| 2022-01-28 2:09 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX L.P. | 1,417,157 6.9% | -500,000 (-26.08%) | View |
| 2021-02-16 4:37 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | FLYING L INVESTMENTS XI LLC | 1,206,051 5.88% | 1,206,051 (New Position) | View |
| 2021-02-16 3:46 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | PERCEPTIVE ADVISORS LLC | 1,296,416 6.4% | 1,296,416 (New Position) | View |
| 2021-02-16 3:34 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,714,269 8.45% | -249,999 (-12.73%) | View |
| 2021-02-12 5:21 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Azamian Bobak R. | 1,915,295 9.04% | 1,915,295 (New Position) | View |
| 2021-02-12 5:19 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Ackermann Michael | 1,467,020 7.07% | 1,467,020 (New Position) | View |
| 2021-02-12 09:42 am Unchanged | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,463,601 12.13% | 0 (Unchanged) | View |
| 2020-10-30 5:00 pm Purchase | 13D | TARSUS PHARMACEUTICALS INC TARS | Horowitz Limited Partnership VIII | 1,987,105 10.3% | 1,987,105 (New Position) | View |
| 2020-10-30 4:00 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,964,268 9.78% | 1,964,268 (New Position) | View |
| 2020-10-28 4:31 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX LLC | 3,245,035 16.2% | 3,245,035 (New Position) | View |
| 2020-10-26 2:16 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,463,601 12.79% | 2,463,601 (New Position) | View |
| 2020-10-23 1:40 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX L.P. | 1,917,157 9.5% | 1,917,157 (New Position) | View |